Concepedia

Marlene E. Haffner

ME

Statistics

Publications

6

Citations

229

H-Index

6

Active since

1998

Affiliations

United States Food and Drug Administration(Current)

Marlene E. Haffner is an author at United States Food and Drug Administration specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoverySubstance AbuseHealth PolicyPublic HealthDrug DevelopmentDrug RepositioningTranslational ResearchHealth Services Research

Publications per year

1998–2012

6

Publications

6

The need for worldwide policy and action plans for rare diseases

John Forman, Domenica Taruscio, Virginia A. Llera et al. · Acta Paediatrica · 2012 · 100 citations · Full text

Does orphan drug legislation really answer the needs of patients?

Marlene E. Haffner, Josep Torrent-Farnell, Paul D Maher · The Lancet · 2008 · 79 citations

Substance Abuse, Primary Care, Health Policy +8

Orphan Drug Development—International Program and Study Design Issues

Marlene E. Haffner · Drug Information Journal · 1998 · 16 citations

Drug Design, Pharmacology, Study Design Issues +6

The impact of the Orphan Drug Act on drug discovery

Marlene E. Haffner, Paul D Maher · Expert Opinion on Drug Discovery · 2006 · 14 citations

Drug Policy, Drug Class, Translational Medicine +20

Orphan Drug Designation and Pharmacogenomics

Paul D Maher, Marlene E. Haffner · BioDrugs · 2006 · 10 citations

Pharmacology, Orphan Drug, Pharmacogenomics +4

1–5 of 6